-Michal Schwarz Researcher Activity Profile

Research Author Detailed Information 

Michal Schwarz Publication Rate By Year

Michal Schwarz has published 2 paper(s) in 1949, 1 paper(s) in 1978, 1 paper(s) in 1982, 1 paper(s) in 1983, 1 paper(s) in 1985, 1 paper(s) in 1986, 2 paper(s) in 1988, 1 paper(s) in 1999, 1 paper(s) in 2001, 1 paper(s) in 2002, 1 paper(s) in 2003, 1 paper(s) in 2005, 2 paper(s) in 2006, 32 paper(s) in 2007, 9 paper(s) in 2008, for a total of 57 research publications in total.

Michal M Schwarz Author Information

LAST NAME: schwarz

FIRST NAME: Michal

INITIALS: m

AFFILIATION:

Papers

Michal Schwarz's Publication Record

1. Mitochondrial carriers and pores: key regulators of the mitochondrial apoptotic program? Year Published: 2007
Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel.
2. Effect of early and late antibiotic treatment in experimental acute pancreatitis in rats. Year Published: 2007
Department of General Surgery, University of Ulm, Ulm, Germany. michael.schwarz@eurosurgery.de
3. Effect of time of insemination relative to ovulation on fertility with liquid and frozen boar semen. Year Published: 2006
4. Helix 8 of the viral chemokine receptor ORF74 directs chemokine binding. Year Published: 2006
Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, Vrije Universiteit Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands.
5. Efficacy and Tolerability of a Fixed Combination of Cinnarizine and Dimenhydrinate versus Betahistine in the Treatment of Otogenic Vertigo : A Double-Blind, Randomised Clinical Study. Year Published: 2007
ENT Clinic Pilsen of Charles University, Prague, Czech Republic.
6. T- and B-lymphocytes in patients with schizophrenia in acute psychotic episode and the course of the treatment. Year Published: 2007
7. Procalcitonin is elevated in the cerebrospinal fluid of patients with dementia and acute neuroinflammation. Year Published: 2007
Sphingotec GmbH, Tulpenweg 6, D-16556 Borgsdorf, Germany.
8. Serum components and activated Ha-ras antagonize expression of perivenous marker genes stimulated by beta-catenin signaling in mouse hepatocytes. Year Published: 2007
Institute of Pharmacology und Toxicology, Department of Toxicology, University of Tuebingen, Germany.
9. Proteome analysis of chemically induced mouse liver tumors with different genotype. Year Published: 2007
10. Comparison of mode of action of four hepatocarcinogens: a model-based approach. Year Published: 2007
Central Unit Biostatistics, German Cancer Research Center, Heidelberg, Germany.
11. Ancrod reduces intracerebral hemorrhage quantified in vivo by magnetic resonance imaging in rats. Year Published: 2007
12. Intensity-Modulated vs. Conformal Radiotherapy of Parotid Gland Tumors: Potential Impact on Hearing Loss. Year Published: 2007
Department of Radiation Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
13. Weekly paclitaxel and carboplatin (PC-W) for patients with primary advanced ovarian cancer: results of a multicenter phase-II study of the NOGGO. Year Published: 2007
14. Gastrointestinal symptoms in 342 patients with Fabry disease: prevalence and response to enzyme replacement therapy. Year Published: 2007
Department of General Pediatrics, University Children's Hospital, Heinrich-Heine-University, Duesseldorf, Germany.
15. Effect of early and late antibiotic treatment in experimental acute pancreatitis in rats. Year Published: 2007
Department of General Surgery, University of Ulm, Ulm, Germany. michael.schwarz@eurosurgery.de
16. Intensity-modulated vs. conformal radiotherapy of parotid gland tumors: potential impact on hearing loss. Year Published: 2007
Department of Radiation Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. e.lamers@nki.nl
17. T- and B-lymphocytes in patients with schizophrenia in acute psychotic episode and the course of the treatment. Year Published: 2007
18. [Introduction of a new intervertebral spacer for cervical fusion: results of a controlled animal study.] Year Published: 2007
19. Serum components and activated Ha-ras antagonize expression of perivenous marker genes stimulated by beta-catenin signaling in mouse hepatocytes. Year Published: 2007
Institute of Pharmacology und Toxicology, Department of Toxicology, University of Tuebingen, Germany.
20. Subtractive single-chain antibody (scFv) phage-display: tailoring phage-display for high specificity against function-specific conformations of cell membrane molecules. Year Published: 2007
Baker Heart Research Institute, Melbourne, Victoria 8008, Australia. s.eisenhardt@gmx.net
21. Arteriovenous fistula and portal hypertension in a child with Down syndrome. Year Published: 2007
Department of Pediatrics C, Schneider Children's Medical Center of Israel, Petah Tiqwa, Israel. yuvaland@post.tau.ac.il
22. [Not Available.] Year Published: 1949
23. [Introduction of a new intervertebral spacer for cervical fusion: results of a controlled animal study.] Year Published: 2007
24. Weekly paclitaxel and carboplatin (PC-W) for patients with primary advanced ovarian cancer: results of a multicenter phase-II study of the NOGGO. Year Published: 2007
25. Arteriovenous fistula and portal hypertension in a child with Down syndrome. Year Published: 2007
Department of Pediatrics C, Schneider Children's Medical Center of Israel, Petah Tiqwa, Israel. yuvaland@post.tau.ac.il
26. [Helping antibodies. Targeted antithrombotic and fibrinolytic therapy] Year Published: 2007
27. Mitochondrial carriers and pores: key regulators of the mitochondrial apoptotic program? Year Published: 2007
Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel.
28. Differential selection for B-raf and Ha-ras mutated liver tumors in mice with high and low susceptibility to hepatocarcinogenesis. Year Published: 2008
29. [Helping antibodies. Targeted antithrombotic and fibrinolytic therapy] Year Published: 2007
30. Gastrointestinal symptoms in 342 patients with Fabry disease: prevalence and response to enzyme replacement therapy. Year Published: 2007
Department of General Pediatrics, University Children's Hospital, Heinrich-Heine-University, Duesseldorf, Germany.
31. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Year Published: 2008
1Unit on the Genetic Basis of Mood and Anxiety Disorders, Mood and Anxiety Disorders Program, US Department of Health and Human Services, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
32. [Not Available.] Year Published: 1949
33. Weekly paclitaxel and carboplatin (PC-W) for patients with primary advanced ovarian cancer: results of a multicenter phase-II study of the NOGGO. Year Published: 2007
34. Arteriovenous fistula and portal hypertension in a child with Down syndrome. Year Published: 2007
Department of Pediatrics C, Schneider Children's Medical Center of Israel, Petah Tiqwa, Israel. yuvaland@post.tau.ac.il
35. A fixed combination of cinnarizine/dimenhydrinate for the treatment of patients with acute vertigo due to vestibular disorders : a randomized, reference-controlled clinical study. Year Published: 2008
36. Intensity-modulated vs. conformal radiotherapy of parotid gland tumors: potential impact on hearing loss. Year Published: 2007
Department of Radiation Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. e.lamers@nki.nl
37. Chemo immunotherapy of advanced breast cancer with BCG. Year Published: 1978
38. Some remarks on the complex behaviour of platelet function during and after prostacyclin treatment. Year Published: 1982
39. Gastric secretion, proinflammatory cytokines and epidermal growth factor (EGF) in the delayed healing of lingual and gastric ulcerations by testosterone. Year Published: 2008
Department of Physiology, Jagiellonian University Medical College, 16 Grzegorzecka Street, 31-531, Cracow, Poland.
40. Decreased sTNF-RI in migraine patients? Year Published: 2003
Department of Neurology, University of Munich, Germany. mempl@ion.ucl.ac.uk
41. [Introduction of a new intervertebral spacer for cervical fusion: results of a controlled animal study] Year Published: 2007
Orthopädisch-Unfallchirurgisches Zentrum, Universitätsklinik Mannheim. ute.schreiner@ortho.ma.uni-heidelberg.de
42. Optic pathway glioma: correlation of imaging findings with the presence of neurofibromatosis. Year Published: 2001
Department of Imaging, Schneider Children's Medical Center of Israel, Petah Tiqva, Israel.
43. Laron syndrome abnormalities: spinal stenosis, os odontoideum, degenerative changes of the atlanto-odontoid joint, and small oropharynx. Year Published: 2002
Department of Imaging, Schneider Children's Medical Center of Israel, Petah Tiqva.
44. MR findings in growth hormone deficiency: correlation with severity of hypopituitarism. Year Published: 1999
Department of Imaging, Schneider Children's Medical Center of Israel, Petah Tikvah.
45. Thiamine deficiency in infants: MR findings in the brain. Year Published: 2005
Department of Imaging, Schneider Children's Medical Center of Israel, Petah Tiqva.
46. Proton therapy in lung cancer: Clinical outcomes and technical issues. A systematic review. Year Published: 2008
ATreP - Provincial Agency for Proton Therapy, Trento, Italy.
47. Rigidity and catalepsy after injections of muscimol into the ventromedial thalamic nucleus: an electromyographic study in the rat. Year Published: 1985
48. GABAergic neurotransmission within the reticular part of the substantia nigra (SNR): role for switching motor patterns and performance of movements. Year Published: 1986
49. Catalepsy after microinjection of haloperidol into the rat medial prefrontal cortex. Year Published: 1988
Max-Planck-Institute for Experimental Medicine, Göttingen, Federal Republic of Germany.
50. Delta-aminovaleric acid antagonizes the pharmacological actions of baclofen in the central nervous system. Year Published: 1988
Max-Planck-Institute for Experimental Medicine, Göttingen, Federal Republic of Germany.
51. Subtractive single-chain antibody (scFv) phage-display: tailoring phage-display for high specificity against function-specific conformations of cell membrane molecules. Year Published: 2007
Baker Heart Research Institute, Melbourne, Victoria 8008, Australia. s.eisenhardt@gmx.net
52. Radiolabelled platelets and prostacyclin in diagnosis and treatment of transplant rejection. Year Published: 1983
53. Proton therapy in lung cancer: clinical outcomes and technical issues. A systematic review. Year Published: 2008
ATreP-Provincial Agency for Proton Therapy, Trento, Italy.
54. Subtractive single-chain antibody (scFv) phage-display: tailoring phage-display for high specificity against function-specific conformations of cell membrane molecules. Year Published: 2007
Baker Heart Research Institute, Melbourne, Victoria 8008, Australia. s.eisenhardt@gmx.net
55. Differential selection for B-raf and Ha-ras mutated liver tumors in mice with high and low susceptibility to hepatocarcinogenesis. Year Published: 2008
56. Gastric secretion, proinflammatory cytokines and epidermal growth factor (EGF) in the delayed healing of lingual and gastric ulcerations by testosterone. Year Published: 2008
Department of Physiology, Jagiellonian University Medical College, 16 Grzegorzecka Street, 31-531, Cracow, Poland.
57. Sex Pheromone of Browntail Moth, Euproctis chrysorrhea (L.): Synthesis and Field Deployment. Year Published: 2008
ashot.khrimiaa@ars.usda.gov.